News|Videos|October 26, 2023
ASCENT Study: Impact of Sacituzumab Govitecan on Metastatic TNBC
Author(s)Nour Abuhadra, MD
Shay Elkins, a patient with metastatic triple-negative breast cancer, discussed her experience with second-line treatment. Dr. Noor provided insights into the positive outcomes from the ASCENT study.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Targeted Ablation Therapy Improves Quality of Life in Pancreatic Cancer
2
RAMPART Trial Highlights Kidney Cancer Treatment Options
3
Understanding Stage 2 Myeloma with Treatment and Next Steps Explained
4
Understanding Stage 2 Vaginal Cancer: Symptoms, Diagnosis, and Treatment
5
